Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. College of Medicine /醫學院
  3. Institute of Medicine/醫學研究所
  4. Survival benefit of tofacitinib in interstitial lung disease associated with anti-MDA5-positive dermatomyositis: a need for further validation
 
  • Details
Options

Survival benefit of tofacitinib in interstitial lung disease associated with anti-MDA5-positive dermatomyositis: a need for further validation

Journal
European Respiratory Journal
Journal Volume
66
Journal Issue
1
Start Page
2500306
ISSN
0903-1936
1399-3003
Date Issued
2025-07
Author(s)
Chih-Wei Tseng
James Cheng-Chung Wei  
DOI
10.1183/13993003.00306-2025
URI
https://scholars.csmu.edu.tw/handle/123456789/5293
SDGs

[SDGs]SDG3

Publisher
European Respiratory Society (ERS)
Type
journal-article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback